Embody vs Revel Health
Two headline figures that expire in different ways.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Embody
Partner
$199/mo
The Flat subscription schedule puts monthly semaglutide at $199 and tirzepatide at $299. Embody also promotes a separate offer, so the selected agreement matters more than the headline. Its disclosures now identify OpenLoop Health and four dispensing partners. The refund restriction on unused bundle months deserves attention before a long commitment.
For
- OpenLoop Health identified as the clinical network
- Four dispensing partners disclosed
- Separate subscription programs explained in legal terms
Against
- Promotional homepage and Flat terms quote different offers
- The assigned pharmacy is not established before intake
- Prepaid unused treatment is generally non-refundable
Pick it for: Readers comparing the standing rate rather than the promotion
Revel Health
Editorial
$149/mo
Revel Health advertises compounded semaglutide at $199 a month by injection and $149 as an oral dissolving tablet, with compounded tirzepatide at $249 and $199 on the same pattern. The oral is the cheaper route on both molecules, which reverses the usual order. Each line also carries a reduced first month, and the seller states that consultation, medication, supplies and shipping are included in the rate. Forty-five states.
For
- Oral priced below the injection on both molecules
- Rate stated to include consultation and shipping
- All four combinations carry a published figure
Against
- Headline first-month rates apply once
- Five states are not served
- Support at a dose step is not described
Pick it for: Readers who want consultation and shipping inside the ongoing figure
Our verdict
Embody advertises a promotional rate against a higher listed one. Revel Health advertises a first month against a higher ongoing rate. Neither headline is what month two costs.
What actually separates them
Embody and Revel Health state different things about published price. Everything else they publish, they publish the same way.
Embody costs $50 more than Revel Health — 34% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,788 at Revel Health against $2,388 at Embody — a difference of $600.
| Embody | Revel Health | |
|---|---|---|
| Published price | $199/mo | $149/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.